{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:18:08Z","timestamp":1761823088919},"reference-count":63,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.vaccine.2008.09.031","type":"journal-article","created":{"date-parts":[[2008,10,2]],"date-time":"2008-10-02T09:00:06Z","timestamp":1222938006000},"page":"6329-6337","source":"Crossref","is-referenced-by-count":25,"title":["Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection"],"prefix":"10.1016","volume":"26","author":[{"given":"Anasuya","family":"Chattopadhyay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Delmas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rema","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Senina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Perlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John K.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2008.09.031_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis\u2014etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2008.09.031_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1128\/MMBR.25.3.249-261.1961","article-title":"Pneumonic plague","volume":"25","author":"Meyer","year":"1961","journal-title":"Bacteriol Rev"},{"issue":"10","key":"10.1016\/j.vaccine.2008.09.031_bib3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199709043371004","article-title":"Multidrug resistance in Yersinia pestis mediated by a transferable plasmid","volume":"337","author":"Galimand","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.031_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2958.2002.03159.x","article-title":"High-frequency conjugative transfer of antibiotic resistance genes to Yersinia pestis in the flea midgut","volume":"46","author":"Hinnebusch","year":"2002","journal-title":"Mol Microbiol"},{"issue":"17","key":"10.1016\/j.vaccine.2008.09.031_bib5","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"283","author":"Inglesby","year":"2000","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.031_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/14760584.7.2.209","article-title":"Current challenges in the development of vaccines for pneumonic plague","volume":"7","author":"Smiley","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2008.09.031_bib7","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1517\/14712598.4.6.965","article-title":"Yersinia pestis (plague) vaccines","volume":"4","author":"Titball","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.031_bib8","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/IAI.67.4.1922-1928.1999","article-title":"Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice","volume":"67","author":"Benner","year":"1999","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2008.09.031_bib9","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1128\/IAI.73.3.1532-1542.2005","article-title":"Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis","volume":"73","author":"Philipovskiy","year":"2005","journal-title":"Infect Immun"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2008.09.031_bib10","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2008.09.031_bib11","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/IAI.64.11.4580-4585.1996","article-title":"Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis","volume":"64","author":"Anderson","year":"1996","journal-title":"Infect Immun"},{"issue":"28","key":"10.1016\/j.vaccine.2008.09.031_bib12","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1016\/S0264-410X(00)00128-6","article-title":"Protection studies following bronchopulmonary and intramuscular immunisation with Yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy","volume":"18","author":"Eyles","year":"2000","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2008.09.031_bib13","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1128\/IAI.63.8.2854-2858.1995","article-title":"Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague","volume":"63","author":"Leary","year":"1995","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2008.09.031_bib14","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1021\/bp050098r","article-title":"Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague","volume":"21","author":"Powell","year":"2005","journal-title":"Biotechnol Prog"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2008.09.031_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: the basis of protection","volume":"12","author":"Williamson","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2008.09.031_bib16","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(96)00303-9","article-title":"A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague","volume":"15","author":"Williamson","year":"1997","journal-title":"Vaccine"},{"issue":"4\u20135","key":"10.1016\/j.vaccine.2008.09.031_bib17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0264-410X(00)00159-6","article-title":"A single dose sub-unit vaccine protects against pneumonic plague","volume":"19","author":"Williamson","year":"2000","journal-title":"Vaccine"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2008.09.031_bib18","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0264-410X(96)00151-X","article-title":"Local and systemic immune response to a microencapsulated sub-unit vaccine for plague","volume":"14","author":"Williamson","year":"1996","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.09.031_bib19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1046\/j.1365-2958.1999.01408.x","article-title":"The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation","volume":"32","author":"Pettersson","year":"1999","journal-title":"Mol Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.09.031_bib20","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1128\/JB.180.5.1207-1214.1998","article-title":"The Yersinia Yop virulon: LcrV is required for extrusion of the translocators YopB and YopD","volume":"180","author":"Sarker","year":"1998","journal-title":"J Bacteriol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.09.031_bib21","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1128\/IAI.65.11.4476-4482.1997","article-title":"Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization","volume":"65","author":"Hill","year":"1997","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.031_bib22","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1128\/IAI.71.4.2234-2238.2003","article-title":"Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis","volume":"71","author":"Hill","year":"2003","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2008.09.031_bib23","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1128\/IAI.62.10.4192-4201.1994","article-title":"Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide","volume":"62","author":"Motin","year":"1994","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.031_bib24","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.vaccine.2006.08.010","article-title":"An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge","volume":"25","author":"Palin","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.031_bib25","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.4049\/jimmunol.133.4.2226","article-title":"Roles of V antigen in promoting virulence and immunity in yersiniae","volume":"133","author":"Une","year":"1984","journal-title":"J Immunol"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2008.09.031_bib26","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1016\/j.vaccine.2004.02.036","article-title":"A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague","volume":"22","author":"Wang","year":"2004","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2008.09.031_bib27","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1086\/507644","article-title":"Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen","volume":"194","author":"Chiuchiolo","year":"2006","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2008.09.031_bib28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/eji.200737799","article-title":"Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205\/CD205-positive mouse dendritic cells","volume":"38","author":"Do","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2008.09.031_bib29","series-title":"Fields\u2019 virology","article-title":"Rhabdoviridae: the viruses and their replication","author":"Rose","year":"2001"},{"issue":"6","key":"10.1016\/j.vaccine.2008.09.031_bib30","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1128\/JVI.72.6.4704-4711.1998","article-title":"Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge","volume":"72","author":"Roberts","year":"1998","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2008.09.031_bib31","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1073\/pnas.92.10.4477","article-title":"Recombinant vesicular stomatitis viruses from DNA","volume":"92","author":"Lawson","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.031_bib32","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1128\/JVI.70.4.2318-2323.1996","article-title":"The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus","volume":"70","author":"Schnell","year":"1996","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2008.09.031_bib33","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1089\/aid.2004.20.989","article-title":"Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes","volume":"20","author":"Egan","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"8","key":"10.1016\/j.vaccine.2008.09.031_bib34","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1128\/JVI.78.8.3930-3940.2004","article-title":"Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol","volume":"78","author":"Ramsburg","year":"2004","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.09.031_bib35","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0092-8674(01)00482-2","article-title":"An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants","volume":"106","author":"Rose","year":"2001","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.vaccine.2008.09.031_bib36","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1128\/JVI.71.8.5982-5989.1997","article-title":"High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses","volume":"71","author":"Kretzschmar","year":"1997","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.09.031_bib37","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1128\/JVI.73.5.3723-3732.1999","article-title":"Attenuated vesicular stomatitis viruses as vaccine vectors","volume":"73","author":"Roberts","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.09.031_bib38","series-title":"Fields\u2019 virology","first-page":"1137","article-title":"Rhabdoviruses","author":"Dietzschold","year":"1996"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.09.031_bib39","first-page":"53","article-title":"Cell-mediated immunity to vesicular stomatitis virus infections in mice","volume":"46","author":"Zinkernagel","year":"1978","journal-title":"Exp Cell Biol"},{"issue":"10","key":"10.1016\/j.vaccine.2008.09.031_bib40","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.09.031_bib41","first-page":"537","article-title":"Development of a new vaccine for the prevention of lassa fever","volume":"2","author":"Geisbert","year":"2006","journal-title":"PLOS Med"},{"issue":"7","key":"10.1016\/j.vaccine.2008.09.031_bib42","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat Med"},{"issue":"22","key":"10.1016\/j.vaccine.2008.09.031_bib43","doi-asserted-by":"crossref","first-page":"11079","DOI":"10.1128\/JVI.75.22.11079-11087.2001","article-title":"Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge","volume":"75","author":"Kahn","year":"2001","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.031_bib44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.virol.2005.06.016","article-title":"Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine","volume":"340","author":"Kapadia","year":"2005","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.vaccine.2008.09.031_bib45","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1128\/JVI.80.9.4447-4457.2006","article-title":"Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge","volume":"80","author":"Natuk","year":"2006","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2008.09.031_bib46","doi-asserted-by":"crossref","first-page":"8900","DOI":"10.1128\/JVI.76.17.8900-8909.2002","article-title":"Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease","volume":"76","author":"Reuter","year":"2002","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.09.031_bib47","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1128\/JVI.78.6.3196-3199.2004","article-title":"Complete protection from papillomavirus challenge after a single vaccination with a vesicular stomatitis virus vector expressing high levels of L1 protein","volume":"78","author":"Roberts","year":"2004","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2008.09.031_bib48","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1128\/JVI.74.10.4652-4657.2000","article-title":"Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies","volume":"74","author":"Schlereth","year":"2000","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.09.031_bib49","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0092-8674(00)80350-5","article-title":"Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection","volume":"90","author":"Schnell","year":"1997","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.vaccine.2008.09.031_bib50","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.virol.2007.04.021","article-title":"Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection","volume":"366","author":"Schwartz","year":"2007","journal-title":"Virology"},{"issue":"24","key":"10.1016\/j.vaccine.2008.09.031_bib51","doi-asserted-by":"crossref","first-page":"15043","DOI":"10.1128\/JVI.79.24.15043-15053.2005","article-title":"A vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals","volume":"79","author":"Ramsburg","year":"2005","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.vaccine.2008.09.031_bib52","doi-asserted-by":"crossref","first-page":"8122","DOI":"10.1073\/pnas.83.21.8122","article-title":"Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase","volume":"83","author":"Fuerst","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.031_bib53","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0092-8674(81)90143-4","article-title":"Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription","volume":"23","author":"Iverson","year":"1981","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.vaccine.2008.09.031_bib54","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/CVI.00398-06","article-title":"Development of in vitro correlate assays of immunity to infection with Yersinia pestis","volume":"14","author":"Bashaw","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.09.031_bib55","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1128\/IAI.73.11.7304-7310.2005","article-title":"Cell-mediated protection against pulmonary Yersinia pestis infection","volume":"73","author":"Parent","year":"2005","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.031_bib56","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/IAI.01529-06","article-title":"Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection","volume":"75","author":"Philipovskiy","year":"2007","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2008.09.031_bib57","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2567.2006.02447.x","article-title":"Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis","volume":"119","author":"Shim","year":"2006","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.031_bib58","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0952-7915(99)80067-3","article-title":"T cell responses to bacterial infection","volume":"11","author":"Kerksiek","year":"1999","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.031_bib59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J Leukoc Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.031_bib60","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1128\/IAI.74.2.1043-1049.2006","article-title":"The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance","volume":"74","author":"Pilione","year":"2006","journal-title":"Infect Immun"},{"issue":"13","key":"10.1016\/j.vaccine.2008.09.031_bib61","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1073\/pnas.0501254102","article-title":"CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization","volume":"102","author":"Malley","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.031_bib62","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.micpath.2004.06.009","article-title":"Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague","volume":"37","author":"Elvin","year":"2004","journal-title":"Microb Pathog"},{"issue":"1","key":"10.1016\/j.vaccine.2008.09.031_bib63","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1128\/IAI.61.1.23-31.1993","article-title":"Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha","volume":"61","author":"Nakajima","year":"1993","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08012334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08012334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T06:12:28Z","timestamp":1684563148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08012334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":63,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0264410X08012334"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.09.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}